A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer’s diseaseStephen Salloway, Paul Aisen, Martin R. Farlow et al.|Nature Medicine|2021Cited by 365
Loss-of-function variants in ABCA7 confer risk of Alzheimer's diseaseDemGene, Hilkka Soininen, James J. Lah et al.|Nature Genetics|2015Cited by 332
The Lipoprotein Receptor LR11 Regulates Amyloid β Production and Amyloid Precursor Protein Traffic in Endosomal CompartmentsKatrin Offe, James J. Lah|Journal of Neuroscience|2006Cited by 281
Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer’s diseaseErik C. B. Johnson, Yudy Milena Leon, Shijia Bian et al.|Nature Medicine|2023Cited by 172
Pharmacologic Inhibition of ROCK2 Suppresses Amyloid-β Production in an Alzheimer's Disease Mouse ModelJeremy H. Herskowitz, James J. Lah|Journal of Neuroscience|2013Cited by 147